PA8441101A1 - Composiciones farmaceuticas - Google Patents

Composiciones farmaceuticas

Info

Publication number
PA8441101A1
PA8441101A1 PA19978441101A PA8441101A PA8441101A1 PA 8441101 A1 PA8441101 A1 PA 8441101A1 PA 19978441101 A PA19978441101 A PA 19978441101A PA 8441101 A PA8441101 A PA 8441101A PA 8441101 A1 PA8441101 A1 PA 8441101A1
Authority
PA
Panama
Prior art keywords
pharmaceutical compositions
lamivudine
zidovudine
understands
hiv
Prior art date
Application number
PA19978441101A
Other languages
English (en)
Inventor
Allen Wayne Wood
Katherine Jeannette Ford
Gary Wayne Goodson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of PA8441101A1 publication Critical patent/PA8441101A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)

Abstract

SE DESCRIBE UNA COMPOSICION FARMACEUTICA Y UN METODO PARA INHIBIR EL VIRUS DE LA INMUNODEFICIENCIA HUMANA (VIH) EL CUAL COMPRENDE ADMINISTRAR A UN PACIENTE INFECTADO POR VIH UNA COMBINACION HOMOGENEA DE LAMIVUDINA, ZIDOVUDINA Y UN LUBRICANTE FARMACEUTICO EN UNA CANTIDAD QUE LOGRA EFICACIA ANTIVIRAL.
PA19978441101A 1996-10-31 1997-10-30 Composiciones farmaceuticas PA8441101A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9622681.6A GB9622681D0 (en) 1996-10-31 1996-10-31 Pharmaceutical compositions

Publications (1)

Publication Number Publication Date
PA8441101A1 true PA8441101A1 (es) 2000-05-24

Family

ID=10802224

Family Applications (1)

Application Number Title Priority Date Filing Date
PA19978441101A PA8441101A1 (es) 1996-10-31 1997-10-30 Composiciones farmaceuticas

Country Status (44)

Country Link
EP (1) EP0941100B1 (es)
JP (1) JP2001502718A (es)
KR (1) KR100551652B1 (es)
AP (1) AP1067A (es)
AR (1) AR009135A1 (es)
AT (1) ATE241364T1 (es)
AU (1) AU736607B2 (es)
BG (1) BG64541B1 (es)
BR (1) BR9712614A (es)
CA (1) CA2270174A1 (es)
CO (1) CO4930269A1 (es)
CY (1) CY2485B1 (es)
CZ (1) CZ296080B6 (es)
DE (1) DE69722433T2 (es)
DK (1) DK0941100T3 (es)
EA (1) EA002437B1 (es)
EE (1) EE03806B1 (es)
ES (1) ES2200204T3 (es)
GB (1) GB9622681D0 (es)
GE (1) GEP20022735B (es)
GT (1) GT199700116A (es)
HK (1) HK1020880A1 (es)
HR (1) HRP970569B1 (es)
HU (1) HU224969B1 (es)
ID (1) ID18698A (es)
IL (1) IL129422A0 (es)
IS (1) IS5024A (es)
MY (1) MY119513A (es)
NO (1) NO317163B1 (es)
NZ (1) NZ335153A (es)
OA (1) OA11038A (es)
PA (1) PA8441101A1 (es)
PE (1) PE10099A1 (es)
PL (1) PL190349B1 (es)
PT (1) PT941100E (es)
SI (1) SI0941100T1 (es)
SK (1) SK284286B6 (es)
SV (1) SV1997000090A (es)
TR (1) TR199900950T2 (es)
UA (1) UA64725C2 (es)
UY (1) UY24766A1 (es)
WO (1) WO1998018477A2 (es)
YU (1) YU19999A (es)
ZA (1) ZA979726B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions
GB9809213D0 (en) * 1998-04-29 1998-07-01 Glaxo Group Ltd Pharmaceutical compositions
US7074417B2 (en) * 2000-10-13 2006-07-11 Advancis Pharmaceutical Corporation Multiple-delayed release anti-viral product, use and formulation thereof
DE60219965T2 (de) * 2002-04-23 2008-01-17 Lupin Ltd., Mumbai Lang wirkende zusammensetzungen enthaltend zidovudine und/oder lamivudine
DE60313657T2 (de) * 2002-11-08 2008-01-03 Smithkline Beecham Corp. Antivirale zusammensetzungen
AU2004206827A1 (en) 2003-01-14 2004-08-05 Gilead Sciences, Inc. Compositions and methods for combination antiviral therapy
AR045841A1 (es) * 2004-09-28 2005-11-16 Richmond Sa Com Ind Y Financie Una composicion farmaceutica solida que comprende al tiazolil metil ester del acido [5s-(5r*, 8r*, 10r*,11r*)] -10- hidroxi-2- metil-5-(1-metiletil)-1-[2-(1-metiletil)-4-tiazolil]-3,6-dioxo-8,11-bis(fenilmetil)-2,4,7,12- tetraazatridecan-13-oico y un procedimiento para prepararla.
WO2011156594A2 (en) 2010-06-09 2011-12-15 Vaccine Technologies, Incorporated Therapeutic immunization in hiv infected subjects receiving stable antiretroviral treatment
CN104203244A (zh) 2012-03-05 2014-12-10 希普拉有限公司 包含拉米夫定、festinnvir和奈韦拉平的抗反转录病毒药物组合物
WO2014130553A2 (en) * 2013-02-20 2014-08-28 Abbvie Inc. Tablet dosage forms

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4950652A (en) * 1987-03-23 1990-08-21 Hem Research, Inc. dsRNAs for combination therapy in the treatment of viral diseases
WO1992020344A1 (en) * 1991-05-16 1992-11-26 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
GB9110624D0 (en) * 1991-05-16 1991-07-03 Glaxo Group Ltd Combinations
GB9622681D0 (en) * 1996-10-31 1997-01-08 Glaxo Group Ltd Pharmaceutical compositions

Also Published As

Publication number Publication date
CO4930269A1 (es) 2000-06-27
SV1997000090A (es) 1998-10-07
IS5024A (is) 1999-04-09
NO992091D0 (no) 1999-04-29
EE03806B1 (et) 2002-08-15
BR9712614A (pt) 1999-10-26
AU5314298A (en) 1998-05-22
EP0941100B1 (en) 2003-05-28
TR199900950T2 (xx) 1999-07-21
BG64541B1 (bg) 2005-07-29
ZA979726B (en) 1999-04-29
EP0941100A2 (en) 1999-09-15
WO1998018477A2 (en) 1998-05-07
PL190349B1 (pl) 2005-11-30
PE10099A1 (es) 1999-03-02
NO992091L (no) 1999-06-29
EA199900345A1 (ru) 2000-02-28
AP1067A (en) 2002-05-01
CZ155799A3 (cs) 1999-10-13
CA2270174A1 (en) 1998-05-07
AP9901519A0 (en) 1999-06-30
UY24766A1 (es) 2000-12-29
ES2200204T3 (es) 2004-03-01
BG103435A (en) 2000-04-28
CY2485B1 (en) 2005-06-03
JP2001502718A (ja) 2001-02-27
IL129422A0 (en) 2000-02-17
PL333143A1 (en) 1999-11-22
CZ296080B6 (cs) 2006-01-11
UA64725C2 (uk) 2004-03-15
ID18698A (id) 1998-04-30
OA11038A (en) 2002-02-06
AU736607B2 (en) 2001-08-02
GB9622681D0 (en) 1997-01-08
HRP970569B1 (en) 2004-10-31
KR20000052893A (ko) 2000-08-25
KR100551652B1 (ko) 2006-02-13
MY119513A (en) 2005-06-30
SK57599A3 (en) 2000-06-12
DE69722433D1 (de) 2003-07-03
ATE241364T1 (de) 2003-06-15
WO1998018477A3 (en) 1998-06-18
NZ335153A (en) 2001-04-27
DE69722433T2 (de) 2004-04-08
NO317163B1 (no) 2004-08-30
GEP20022735B (en) 2002-07-25
AR009135A1 (es) 2000-03-08
SI0941100T1 (en) 2003-12-31
EA002437B1 (ru) 2002-04-25
DK0941100T3 (da) 2003-09-01
HUP0000344A3 (en) 2002-04-29
SK284286B6 (sk) 2005-01-03
EE9900175A (et) 1999-12-15
GT199700116A (es) 1999-04-22
HU224969B1 (en) 2006-04-28
HUP0000344A2 (hu) 2001-05-28
HRP970569A2 (en) 1998-08-31
HK1020880A1 (en) 2000-05-26
PT941100E (pt) 2003-10-31
YU19999A (sh) 2000-10-30

Similar Documents

Publication Publication Date Title
ES2171039T3 (es) Producto que comprende al menos un rna bicatenario en asociacion con al menos un interferon para el tratamiento de la hepatitis viral.
UY25330A1 (es) Nuevos macrólidos
ES2179193T3 (es) Combinaciones sinergicas de zidovudina, 1592u89 y 3tc.
AR005703A1 (es) Oxazolidinonas sustituidas, procedimiento para su preparacion, uso de las mismas para preparar medicamentos y medicamentos que las contienen
YU7296A (sh) Farmaceutska kompozicija koja sadrži kombinaciju jedne protivvirusne supstance i jednog protivzapaljenskog glukokortikoida
BR0015188A (pt) Composições farmacêuticas
PA8441101A1 (es) Composiciones farmaceuticas
BR9807383A (pt) Formulação farmacêutica que compreende amoxicilina e clavulanato
ES2192201T3 (es) Compuestos de piranona utiles para el tratamiento de infecciones retrovirales.
BR9611802A (pt) Composições farmacêuticas
ES2185760T3 (es) Composicion farmaceutica para el tratamiento del herpes.
RS20050066A (en) Aqueous 2,6-diisopropylphenol pharmaceutical compositions
ES2098140T3 (es) Liosferas que contienen gonadotropina.
PA8586201A1 (es) Nuevas formulaciones de liberacion prolongada inyectables
ES2061688T3 (es) Composiciones farmaceuticas que comprenden una calcitonina y un glicirricinato como mejorador de la absorcion.
ES2128519T3 (es) Nuevas pirido-tiadiazinas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
BR9808719A (pt) Composições de higiene pessoal contendo uma base de mascaramento de odor
ES2182255T3 (es) Agente de blanqueo fluorescente.
AR032499A1 (es) Composiciones
BR9916575A (pt) Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa
BR9711647A (pt) Novos derivados de ácido dicafeoilquìmico, seu uso, composições com os mesmos e métodos de tratamento usando-os.
BRPI0814725B8 (pt) uso da composição antiviral
EA200000997A1 (ru) Гомогенные фармацевтические композиции, содержащие абакавир, ламивудин и зидовудин
ES2158496T3 (es) Mezclas aislables a partir de granos de eugenia jambolana lamarck, su preparacion y la utilizacion de estas mezclas y de algunos de sus constituyentes como medicamentos.
BR9912142A (pt) 6-benzil-4-oxipirimidinas substituìdas, processopara sua preparação e composições contendo-as